Navigation Links
Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
Date:2/26/2013

TOKYO, Feb. 27, 2013 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI) ) to the Japanese Ministry of Health, Labor and Welfare. Taiho Pharmaceutical is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer.

The application for approval is based on the results of a Phase II clinical trial (Study 10040030) conducted at 20 facilities throughout Japan. It was a randomized, double-blind comparative study of TAS-102 and a placebo involving 172 patients with unresectable, advanced, recurrent colorectal cancer that was refractory to the standard chemotherapy of at least two or more regimens containing fluoropyrimidine, irinotecan, and oxaliplatin. The results indicated that the group administered TAS-102 had improved overall survival rates (median overall survival: 9.0 months vs. 6.6 months) and a significantly reduced risk of mortality (HR: 0.56, p=0.0011). The most frequently reported adverse drug reaction with a CTCAE grade of 3 or higher was neutropenia. Grade 3 or higher diarrhea, fatigue, nausea, and other adverse reactions were no more than 10%. Taiho Pharmaceutical is currently proceeding with a global Phase III clinical trial of TAS-102 in a similar colorectal cancer population (RECOURSE) with the ultimate goal of global registration and commercialization of the agent.

Taiho Pharmaceutical believes that TAS-102 will make a significant contribution to cancer patients and will continue its development efforts to broaden its use.

About TAS-102
TAS-102 is an antitumor agent composed of a combination of trifluorothymidine (FTD), a nucleoside that incorporates into DNA and inhibits a variety of gene
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
2. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
3. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
5. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
6. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
7. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
10. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
11. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy ... are considered the most sensitive method for detecting colorectal ... in preventing cancer cases 3 . EndoChoice ® ... Fuse™ system significantly improves the accuracy of this procedure ... colonoscopists. EndoChoice will be discussing these clinical trial results ...
(Date:5/17/2013)... NEW YORK , May 17, 2013 ... of the most important ways in which mankind depends ... New York Botanical Garden,s multifaceted exhibition Wild Medicine: ... Italian Renaissance Garden, on view from May 18 ... http://photos.prnewswire.com/prnh/20130517/NY16603 ) The featured exhibition,s many attractions ...
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
... (NYSE: KR ) said today it is recalling ... in its family of stores because the products have the ... names in the 31 states where Kroger operates are included ... Less, Fry,s, King Soopers, Smith,s, Dillons, QFC, City Market, Foods ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced ... research collaboration with Alexza Pharmaceuticals, Inc. (Nasdaq: ... the treatment of breakthrough pain using Alexza,s Staccato(R) inhalation ... Phase I clinical testing and will be returned to ...
Cached Medicine Technology:Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 3Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 2Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration 3
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law ... lawsuit on behalf of a-24-year-old financial analyst rendered quadriplegic ... The diving accident lawsuit, which was filed in the Supreme ... Defendant held the property out as a bathing beach, but ... area. (Case No. 34556/12) , According to the diving accident ...
(Date:5/19/2013)... Heights, NJ (PRWEB) May 20, 2013 ... have joined Summit Medical Group: David A. Abrutyn, M.D., ... will continue to see patients at their current location, ... A. Abrutyn, M.D., has expertise in sports medicine, with ... also treats pediatric, adolescent, and adult patients for a ...
(Date:5/19/2013)... 19, 2013 At a May ... of Asian Pacific Physicians (NCAPIP), the Pacific Chronic ... Association of Chronic Disease Directors (NACDD), presented a ... systems, diabetes, and non-communicable diseases (NCDs) in the ... published in the Hawaii Journal of Medicine and ...
(Date:5/19/2013)... Kathleen Doheny HealthDay Reporter , , SATURDAY, ... may help those with Crohn,s disease overcome the ... inflammatory bowel disease, according to new research. ... physical, emotional and general fatigue, greater quality of ... daily living," said Tara Raftery, a research dietitian ...
(Date:5/19/2013)... 19, 2013 Healthcare leaders will gather ... at the Walt Disney World Swan and Dolphin in ... chain innovation, care delivery and healthcare reform and implementation. ... all healthcare markets, with consolidation, efficiency and ... said Todd Ebert, Amerinet president and CEO. “There is ...
Breaking Medicine News(10 mins):Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2
... Texas M. D. Anderson Cancer Center have found that ... growth factor expression are associated with poor survival in ... presented in a poster session today at the Society ... , Sex cord-stromal ovarian tumors are rare, accounting ...
... 5 Stephen H. Schneider, Ph.D.,professor of Environmental ... , a,climatologist and cancer survivor who shared the ... Gore, will be the keynote speaker at the ... FireSky Hotel in,Scottsdale. The conference attracts health care ...
... CINCINNATI, Feb. 5 LCA-Vision Inc. (Nasdaq: ... services under the Lasik Plus (R) brand, announces that ... Officer Michael J. Celebrezze will hold a conference call ... a.m. Eastern time to discuss management,s plan to drive ...
... Mich. --- Nearly 70 percent of minority women agree ... of the key findings of a Michigan State University ... breast cancer screenings. , The study of 341 Arab-American, ... of medical mistrust and assess the impact on whether ...
... Inc. (Pink Sheets: SYNJ) reports that it has engaged in ... the marketing campaign for the acquisition of and/or the start ... the "Director of Marketing" will be to coordinate and develop ... doctors, hospitals, and businesses in the specific location of each ...
... Tomorrow, millions of Americans will wear red to highlight ... as many women die from heart disease as breast cancer in ... primary care doctors still don,t know that heart attacks kill more ... women to continue wearing red once a week, to help sound ...
Cached Medicine News:Health News:Angiogenesis linked to poor survival in patients with rare type of ovarian cancer 2Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 2Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 3Health News:Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists 4Health News:LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6 2Health News:LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6 3Health News:MSU study finds high level of medical mistrust among minority women impacts quality of health care 2Health News:Syndication Inc. Seeks 'Director of Marketing' for 'Sy-Med Decompression Centers'; BOD Considers Adding a 'Green Energy' New Company Subsidiary to its Ranks 2Health News:'Go Red for Women' Gets Stronger by the Week 2
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
Innovative design, highly versatile optical system for ENT and neurosurgery....
The OPMI Neuro/NC4 System is the system of choice for integration with every major Image Guided Surgery (IGS). It can be mounted on NC4 floorstand or ceiling mount....
The Leica M500 OH3 is an advanced surgical microscope used by neurosurgeons. It is a smart system combining the best optical performance available on the market with an innovative and unique stand....
Medicine Products: